Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Concentra Biosciences, LLC — Jounce Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Concentra Biosciences, LLC

Concentra Biosciences, LLC

10% owner at Jounce Therapeutics, Inc. · on record since May 5, 2023

Insider trading activity of Concentra Biosciences, LLC

Transactions on record: 1; since May 5, 2023

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing May 5, 2023

Figures computed from official regulatory filings — methodology.

Companies where Concentra Biosciences, LLC has traded

Jounce Therapeutics, Inc.1 tx · $97.4M · May 5, 2023

Track record of Concentra Biosciences, LLC

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Concentra Biosciences, LLC

Co-insiders of Concentra Biosciences, LLC

CELGENE CORP /DE/Jounce Therapeutics, Inc.
Celgene Switzerland LLCJounce Therapeutics, Inc.
Cole Hugh MJounce Therapeutics, Inc.
Concentra Merger Sub, Inc.Jounce Therapeutics, Inc.
Diaz LuisJounce Therapeutics, Inc.
Drapkin Kimberlee CJounce Therapeutics, Inc.
Duncan Barbara GayleJounce Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

GILEAD SCIENCES INCJounce Therapeutics, Inc.

Hadley Harbor Master Investors (Cayman) L.P.Jounce Therapeutics, Inc.

Higgons John DuncanJounce Therapeutics, Inc.

Iannone RobertJounce Therapeutics, Inc.

Kamen RobertJounce Therapeutics, Inc.

KARSEN PERRY AJounce Therapeutics, Inc.

LEVIN MARK JJounce Therapeutics, Inc.

MURRAY RICHARD /CA/Jounce Therapeutics, Inc.

Pfeffer CaryJounce Therapeutics, Inc.

Raythatha JigarJounce Therapeutics, Inc.

Salter-Cid LuisaJounce Therapeutics, Inc.

STARR KEVIN PJounce Therapeutics, Inc.

TANG CAPITAL MANAGEMENT LLCJounce Therapeutics, Inc.

TANG CAPITAL PARTNERS LPJounce Therapeutics, Inc.

TANG KEVIN CJounce Therapeutics, Inc.

TEPPER ROBERT IJounce Therapeutics, Inc.

Third Rock Ventures GP III, L.P.Jounce Therapeutics, Inc.

Third Rock Ventures GP II, L.P.Jounce Therapeutics, Inc.

Third Rock Ventures III, L.P.Jounce Therapeutics, Inc.

Third Rock Ventures II, L.P.Jounce Therapeutics, Inc.

Trehu ElizabethJounce Therapeutics, Inc.

TRV GP III, LLCJounce Therapeutics, Inc.

TRV GP II, LLCJounce Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Jounce Therapeutics, Inc.	May 5, 2023	Other	10,000	9,737.70 USD	$97.4M	SEC